Cardiocomm Solutions Confirms Australian Regulatory Clearance For Over The Counter (OTC) Sales Of The Heartcheck™ ECG PEN

Cardiac Innovations Australia will promote sales of HeartCheck™ devices to medical and retail markets

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced that it has received clearance from the Australian Department of Health, Therapeutics Goods Administration (“TGA”) for the sale and marketing of their hand-held ECG monitoring devices known as the HeartCheck™ ECG PEN, the HeartCheck™ ECG Monitor and GEMS™ Home in Australia.

CardioComm Solutions previously announced that the Australian TGA granted a certificate for the sale of the Company’s GEMS™ WIN medical software technologies and that the Company had signed Cardiac Innovations Australia Pty. Ltd. (“Cardiac Innovations”) to be the Company’s representative and distributor of its products in Australia. The recent TGA clearance for CardioComm Solutions now provides an expanded sales opportunity for the HeartCheck™ ECG devices and associated SMART Monitoring ECG service solution into the Australian medical, allied health,  and consumer markets.

The handheld HeartCheck™ ECG devices can be connected to a Windows based computer to upload recorded ECGs to CardioComm Solutions’ SMART Monitoring ECG reading service.  This ECG management and interpretation solution will provide physician interpreted or technician triaged ECG reports to the consumer within one hour on a fee-for-service basis.  CardioComm Solutions’ current infrastructure allows the SMART Monitoring ECG service to support ECG transmissions from anywhere globally. With the Australian clearance, the Company will be looking to expand ECG services to support arrhythmia management of patients through a localized SMART Monitoring installation and ECG call service..

CardioComm Solutions has been working to globally expand its two main business verticals involving the sale of its consumer-based, OTC HeartCheck™ ECG monitoring products and their newly released, physician/hospital focused GEMS™ WIN ECG management solutions. The Company has approvals for the sale of the HeartCheck™ devices in Canada, the United States of America, the European Union, China and Australia.

More information regarding the HeartCheck™ products and SMART monitoring solutions is available at the Company’s web site

download pdf

Leave a Comment